MONTANIDE ISA 51 VG
MONTANIDE ISA 51 VG is a vaccine adjuvant composed of a light mineral oil and a surfactant system designed to make a water-in-oil emulsion.
It has been used since 1992 in more than 150 clinical trials related to therapeutic vaccines against various diseases such as cancer, HIV and autoimmune diseases.
MONTANIDE ISA 51 VG has proved to be a very efficient adjuvant, activating the cellular and the humoral immune response. It has been administered to more than 10,000 patients throughout the world.
SEPPIC has gathered all toxicity studies and clinical experiences in an Investigator’s brochure. SEPPIC has also filed a DMF in the US, Canada and Japan.
From pre-clinical to vaccine commercialization, SEPPIC provides full support to make your vaccine development a success.
Example: Validation and qualification of the emulsion, process optimization, regulatory support, adapted batch size and packaging, etc.
SEPPIC ensures a complete GMP process for the manufacture of its adjuvants, from raw materials to QA batch release. Sterile grades are manufactured under aseptic conditions in a pharmaceutical facility.